MDL-73775

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMDL-73775
Drug Alias NameMDL-73775
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IIa inhibitors
TargetsProthrombin
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst Marion Roussel Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A